Hospitalization in dialysis care
Not Applicable
- Conditions
- End Stage Renal Disease requiring hemodialysisUrological and Genital DiseasesChronic kidney disease, stage 5
- Registration Number
- ISRCTN54337309
- Lead Sponsor
- ytics Health AB
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Ongoing
- Sex
- All
- Target Recruitment
- 75
Inclusion Criteria
1. Provision of informed consent prior to any study specific procedures
2. Female or male 18 years of age or older
3. Subjects in dialysis care or subjects in potential of renal dialysis
4. Subject must be able to read and understand informed consent and questionnaires in the provided languages
Exclusion Criteria
The investigator will individually judge criteria for exclusion of any patient
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <br> 1. Quality of life, measured using the KDQOL(TM)-36 (Kidney Disease Quality of Life - short form 36) once monthly<br> 2. Subjective wellbeing, measured using daily questionnaire at each dialysis treatment<br>
- Secondary Outcome Measures
Name Time Method ot provided at time of registration
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link chronic kidney disease progression to hospitalization risk in hemodialysis patients?
How does the observational design of ISRCTN54337309 contribute to understanding hospitalization predictors in ESRD?
Are there specific biomarkers identified in the trial that correlate with hospitalization outcomes in stage 5 CKD patients?
What adverse events are commonly associated with dialysis care and how are they managed in clinical practice?
How does the trial's focus on urological diseases intersect with current research on renal failure comorbidities?